Get the Stockscreener App
24.80
6.73%
-1.79
Doximity Inc stock is traded at $24.80, with a volume of 4.05M.
It is down -6.73% in the last 24 hours and up +13.76% over the past month.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
See More
Previous Close:
$26.59
Open:
$26.615
24h Volume:
4.05M
Relative Volume:
0.75
Market Cap:
$4.42B
Revenue:
$644.86M
Net Income/Loss:
$196.05M
P/E Ratio:
25.28
EPS:
0.9812
Net Cash Flow:
$317.50M
1W Performance:
-9.49%
1M Performance:
+13.76%
6M Performance:
-0.88%
1Y Performance:
-60.97%
1-Day Range:
$24.80
$26.70
1-Week Range:
$24.36
$26.94
52-Week Range:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.80 | 4.45B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Downgrade | Truist | Buy → Hold |
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity AI Tools Fuel Physician Engagement Growth Amid Healthcare Digital Shift - Streetwise Reports
Doximity (NYSE:DOCS) Trading Down 5.6%Here's Why - MarketBeat
Clinical AI Use Surges as Revenue Climbs & Doctors Embrace New Tools - Streetwise Reports
DOCS|Doximity Inc|Price:26.375|Chg%:-0.215 - TradingKey
Doximity (DOCS) Q1 2027 Earnings Call Transcript - AOL.com
Royal Bank of Canada Has $4.81 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity Inc (DOCS) Shares Surge 6.4% -- What GF Score of 86 Tel - GuruFocus
Doximity Doubled, Then Gave Most of It Back. Here’s Why the Market Doesn’t Trust the Rally - Yahoo Finance
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo! Finance Canada
Doximity (NYSE: DOCS) insider schedules 1,770-share stock option sale - Stock Titan
Truist Lifts Doximity Target to $24 and Stays on Hold - Yahoo Finance UK
DOCS Stock Soars After CEO Says Clinical AI Outperformed Anthropic, Wall Street Lifts Price Targets - Stocktwits
Rapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know - TradingView
Truist raises Doximity stock price target on updated model By Investing.com - Investing.com Nigeria
Truist raises Doximity stock price target on updated model - Investing.com
Is Doximity Inc (DOCS) a Bargain After 4.3% Drop? GF Value Says Undervalued - GuruFocus
Mizuho Securities Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $28 - Moomoo
Doximity director Timothy Cabral sells $293,325 in company stock By Investing.com - Investing.com India
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance UK
Doximity director Timothy Cabral sells $293,325 in company stock - Investing.com
First Trust Advisors LP Cuts Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Timothy Cabral Sells 7,500 Shares of Doximity (NYSE:DOCS) Stock - MarketBeat
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup - The Motley Fool
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup - The Motley Fool
Morgan Stanley Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $35 - moomoo.com
J.P. Morgan Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $31 - Moomoo
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool - TIKR.com
DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures - Yahoo Finance
Doximity (NYSE:DOCS) Shares Gap DownHere's What Happened - MarketBeat
Wells Fargo Downgrades Doximity to Underweight From Equalweight, Price Target is $18 - marketscreener.com
Wells Fargo downgrades Doximity stock rating on valuation concerns - Investing.com
Wells Fargo downgrades Doximity stock rating on valuation concerns By Investing.com - Investing.com South Africa
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 7.34% Potential Upside in the Healthcare Sector - directorstalkinterviews.com
Janus Henderson Group PLC Sells 462,468 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Stock Fair Value Rises After Split Analyst Views On AI Growth - Yahoo Finance
Doximity, Inc. $DOCS Shares Purchased by Quantinno Capital Management LP - MarketBeat
DOXIMITY, INC. : RAYMOND JAMES RAISES TARGET PRICE TO $38 FROM $23 - webull.com
Doximity (DOCS) Is Up 31.0% After Raising Revenue Outlook On Clinical AI AdoptionHas The Bull Case Changed? - Yahoo Finance
Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On Friday - Sahm
Why Doximity Stock Skyrocketed on Friday - The Motley Fool
Does Doximity’s Q1 Beat And Higher Guidance Alter The Bull Case For DOCS’ AI Platform? - webull.com
Doximity: I Called The Pop Over A Month Ago, But Now Is The Time To Wait (Rating Downgrade) - Seeking Alpha
Doximity Q1 Earnings Call Highlights - TradingView
Doximity, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
SK Hynix, SpaceX, Doximity, Trade Desk, Rigetti, Coherent, and More Stocks That Explain Today’s Market - Barron's
Daily Digest: What SaaSpocalypse? S.F. software stocks soar - The Business Journals
Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July - Benzinga
Why Doximity Stock Is Soaring 38% After an Earnings Miss - Barron's
Why Doximity Stock Is Up 80% - Yahoo Finance
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
35.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):